Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label extension study of intraventricular valproate for focal seizures of temporal lobe origin
MOH_2021-08-11_010200Phase 2Not yet recruiting
- Sponsor
- Cerebral Therapeutics
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of valproic acid in epilepsy and temporal lobe epilepsy (TLE), sponsored by Cerebral Therapeutics. Planned start Aug 2021; status: not yet recruiting.
02
Drugs
valproic acid
03
Conditions
epilepsytemporal lobe epilepsy (TLE)
Beyond the preview
Go deeper on MOH_2021-08-11_010200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2021-08-11_010200.